• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

    6.930 -0.040 (-0.57%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Recursion Pharmaceuticals Inc Cl A

    < Previous 1 2
    ...
    7 8 9 10 11 12 13 14 Next >
    1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid
    One of these players could win in AI -- and in the healthcare market, in general. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Is Recursion Pharmaceuticals Stock a Buy Now?
    The company has grabbed plenty of headlines recently. 
    Via The Motley Fool
    2 Cathie Wood Stocks I'm Bullish On
    These two next-gen biotechs could be outstanding buys for patient investors. 
    Via The Motley Fool
    2 AI Stocks That Aren't Worth the Hype
    Even if you're bullish on AI, you may want to think twice about buying shares of these two companies. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Cathie Wood's Ark Invest Sells Nearly $4M Worth Of NVIDIA Shares — Does It Herald Shift To Undervalued AI Gems?
    On Monday, Cathie Wood-led Ark Invest made a notable move by selling nearly $4 million worth of NVIDIA Corp (NASDAQ:NVDA) shares. This ... 
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    2 Cathie Wood Stocks That Could Deliver Exponential Returns
    These two cutting-edge healthcare companies could be significantly undervalued right now. 
    Via The Motley Fool
    Is Recursion Pharmaceuticals Stock a Buy?
    This small-cap stock hopes to revolutionize drug discovery with the help of AI. 
    Via The Motley Fool
    AI Investing: 12 Possible Ways To Maximize Your Returns
    It all comes down to playing it smart and doing your research and to help you with that we present 12 micro/small cap AI&R stocks with descriptions of their businesses and their price-to-sales ratios,... 
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend
    Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today. 
    Via InvestorPlace
    3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too
    Cathie Wood is loading up on these healthcare stocks. 
    Via The Motley Fool
    Better Growth Stock: Recursion Pharmaceuticals vs. CRISPR Therapeutics
    They're both liable to grow by a lot, but one of them is a safer bet in the near term. 
    Via The Motley Fool
    3 AI Drug Discovery Stocks to Watch
    The high cost of developing drugs makes the use of artificial intelligence a natural fit for pharmaceutical companies. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
    Find out why analysts have such high expectations for these stocks. 
    Via The Motley Fool
    AI Integration In Biotech & Pharma: Companies Positioned To Benefit
    The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care.... 
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Where Will Recursion Pharmaceuticals Be in 3 Years?
    This biotech could still be a long way from having a drug on the market in 2026. 
    Via The Motley Fool
    2 Brilliant Growth Stocks With Upsides of About 70%, According to Wall Street
    Wall Street analysts foresee these pre-commercial-stage drugmakers rocketing higher over the next 12 months. 
    Via The Motley Fool
    3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains
    These biotech stocks to buy and hold offer tremendous upside blending long-term potential with healthcare advances. 
    Via InvestorPlace
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
    REC-3964 has been well tolerated in healthy volunteers with no reported serious adverse events. Recursion to explore initiating a Phase 2 proof-of-concept study in patients with recurrent... 
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again
    The famous growth investor has been making some interesting stock moves lately. 
    Via The Motley Fool
    Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe
    Both businesses have a lot to prove. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Cathie Wood's Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks
    The Ark Invest CEO continues to trim Shopify holdings to fund some big purchases. 
    Via The Motley Fool
    3 Clever Tricks to Find Winning Biotech Stocks
    You'll need to dig into company details, but the effort is worthwhile. 
    Via The Motley Fool
    AI Bubble Stocks Deflating, Down 14% So Far In August
    13 artificial intelligence and related stocks have dramatically outpaced the sector in general since the AI&R bubble began to inflate at the end of April. MTD, however, they have declined 13.6%, on... 
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company's Stock Instead
    Via Benzinga
    Want to Get Rich? 3 Game-Changing Biotech Stocks to Buy Right Now
    Biotech stocks may offer some of the most explosive opportunities on the market. Here are three with major catalysts nearing. 
    Via InvestorPlace
    3 Green Flags for Biotech Stocks in 2023 and Beyond
    The industry is changing rapidly, and for the better. 
    Via The Motley Fool
    Cathie Wood's Ark Invest Continues To Sell Shopify Shares Amid Q2 Ripples
    Via Benzinga
    < Previous 1 2
    ...
    7 8 9 10 11 12 13 14 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.